Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000092696

Apexbio Technology LLC Carvedilol Phosphate 610309-89-2 25g
SDP

Catalog No. 5000092696
Encompass_Preferred

Carvedilol phosphate (CAS 610309-89-2) is a non-selective beta-adrenoceptor and alpha-1 receptor antagonist targeting adrenergic receptors It is designed to inhibit sympathetic nervous system signaling thereby regulating cardiovascular function and suppressing lipid peroxidation Carvedilol phosphate exerts its biological activity primarily through blockade of beta and alpha-1 adrenergic receptors and inhibition of lipid peroxidation In in vitro studies carvedilol phosphate demonstrates autophagy induction and inhibition of NLRP3 inflammasome activation with reported IC50 values for beta-adrenergic blockade typically in the nanomolar-to-low micromolar range depending on receptor subtype and assay conditions Based on these pharmacological properties carvedilol phosphate holds research potential in hypertension congestive heart failure myocardial ischemia and inflammatory response studies

Catalog No. 50-000-92696 Supplier Apexbio Technology LLC Supplier No. C640425000
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Carvedilol phosphate (CAS 610309-89-2) is a non-selective beta-adrenoceptor and alpha-1 receptor antagonist targeting adrenergic receptors It is designed to inhibit sympathetic nervous system signaling thereby regulating cardiovascular function and suppressing lipid peroxidation Carvedilol phosphate exerts its biological activity primarily through blockade of beta and alpha-1 adrenergic receptors and inhibition of lipid peroxidation In in vitro studies carvedilol phosphate demonstrates autophagy induction and inhibition of NLRP3 inflammasome activation with reported IC50 values for beta-adrenergic blockade typically in the nanomolar-to-low micromolar range depending on receptor subtype and assay conditions Based on these pharmacological properties carvedilol phosphate holds research potential in hypertension congestive heart failure myocardial ischemia and inflammatory response studies

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.